FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571279353> ?p ?o ?g. }

• W2571279353 endingPage "624" @default.
• W2571279353 startingPage "618" @default.
• W2571279353 abstract "Current conditioning regimens provide insufficient disease control in relapsed/refractory acute leukemia patients undergoing hematopoietic stem cell transplantation (HSCT) with active disease. Intensification of chemotherapy and/or total body irradiation (TBI) is not feasible because of excessive toxicity. Total marrow and lymphoid irradiation (TMLI) allows for precise delivery and increased intensity treatment via sculpting radiation to sites with high disease burden or high risk for disease involvement, while sparing normal tissue. We conducted a phase I trial in 51 patients (age range, 16 to 57 years) with relapsed/refractory acute leukemia undergoing HSCT (matched related, matched unrelated, or 1-allele mismatched unrelated) with active disease, combining escalating doses of TMLI (range, 1200 to 2000 cGy) with cyclophosphamide (CY) and etoposide (VP16). The maximum tolerated dose was declared at 2000 cGy, as TMLI simulation studies indicated that >2000 cGy might deliver doses toxic for normal organs at or exceeding those delivered by standard TBI. The post-transplantation nonrelapse mortality (NRM) rate was only 3.9% (95% confidence interval [CI], .7 to 12.0) at day +100 and 8.1% (95% CI, 2.5 to 18.0) at 1 year. The cumulative incidence of grades II to IV acute graft-versus-host disease (GVHD) was 43.1% (95% CI, 29.2 to 56.3) and for grade III and IV, it was 13.7% (95% CI, 6.9 to 27.3). The day +30 complete remission rate for all patients was 88% and was 100% for those treated at 2000 cGy. The overall 1-year survival was 55.5% (95% CI, 40.7 to 68.1). The TMLI/CY/VP16 conditioning regimen is well tolerated at TMLI doses up to 2000 cGy with a low 100-day and 1-year NRM rate and no increased risk of GVHD with higher doses of radiation." @default.
• W2571279353 created "2017-01-13" @default.
• W2571279353 creator A5004910687 @default.
• W2571279353 creator A5014867897 @default.
• W2571279353 creator A5020684790 @default.
• W2571279353 creator A5024492683 @default.
• W2571279353 creator A5025887498 @default.
• W2571279353 creator A5026632776 @default.
• W2571279353 creator A5030685440 @default.
• W2571279353 creator A5033267787 @default.
• W2571279353 creator A5034017455 @default.
• W2571279353 creator A5038541414 @default.
• W2571279353 creator A5039118991 @default.
• W2571279353 creator A5039374832 @default.
• W2571279353 creator A5040369089 @default.
• W2571279353 creator A5045067253 @default.
• W2571279353 creator A5046784402 @default.
• W2571279353 creator A5048042606 @default.
• W2571279353 creator A5058365130 @default.
• W2571279353 creator A5059748968 @default.
• W2571279353 creator A5062110857 @default.
• W2571279353 creator A5065052780 @default.
• W2571279353 creator A5065938090 @default.
• W2571279353 creator A5070193149 @default.
• W2571279353 creator A5071412954 @default.
• W2571279353 creator A5078986373 @default.
• W2571279353 creator A5083138054 @default.
• W2571279353 creator A5086494836 @default.
• W2571279353 creator A5087735259 @default.
• W2571279353 creator A5091818686 @default.
• W2571279353 date "2017-04-01" @default.
• W2571279353 modified "2023-10-17" @default.
• W2571279353 title "Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia" @default.
• W2571279353 cites W1491993932 @default.
• W2571279353 cites W1511526973 @default.
• W2571279353 cites W1530764705 @default.
• W2571279353 cites W1536678688 @default.
• W2571279353 cites W1562876511 @default.
• W2571279353 cites W1579352764 @default.
• W2571279353 cites W162979044 @default.
• W2571279353 cites W1937469588 @default.
• W2571279353 cites W1954992673 @default.
• W2571279353 cites W1973177688 @default.
• W2571279353 cites W1994353303 @default.
• W2571279353 cites W2008349138 @default.
• W2571279353 cites W2013452087 @default.
• W2571279353 cites W2018225125 @default.
• W2571279353 cites W2035502715 @default.
• W2571279353 cites W2052690356 @default.
• W2571279353 cites W2054836967 @default.
• W2571279353 cites W2071579945 @default.
• W2571279353 cites W2086891287 @default.
• W2571279353 cites W2094310043 @default.
• W2571279353 cites W2102124437 @default.
• W2571279353 cites W2104723706 @default.
• W2571279353 cites W2117974708 @default.
• W2571279353 cites W2122657363 @default.
• W2571279353 cites W2126021331 @default.
• W2571279353 cites W2126661483 @default.
• W2571279353 cites W2143034151 @default.
• W2571279353 cites W2159507916 @default.
• W2571279353 cites W2160115655 @default.
• W2571279353 cites W2167685544 @default.
• W2571279353 cites W2410103158 @default.
• W2571279353 cites W4240283302 @default.
• W2571279353 cites W4244166141 @default.
• W2571279353 cites W4376595466 @default.
• W2571279353 cites W71007469 @default.
• W2571279353 doi "https://doi.org/10.1016/j.bbmt.2017.01.067" @default.
• W2571279353 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5382014" @default.
• W2571279353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28087456" @default.
• W2571279353 hasPublicationYear "2017" @default.
• W2571279353 type Work @default.
• W2571279353 sameAs 2571279353 @default.
• W2571279353 citedByCount "77" @default.
• W2571279353 countsByYear W25712793532017 @default.
• W2571279353 countsByYear W25712793532018 @default.
• W2571279353 countsByYear W25712793532019 @default.
• W2571279353 countsByYear W25712793532020 @default.
• W2571279353 countsByYear W25712793532021 @default.
• W2571279353 countsByYear W25712793532022 @default.
• W2571279353 countsByYear W25712793532023 @default.
• W2571279353 crossrefType "journal-article" @default.
• W2571279353 hasAuthorship W2571279353A5004910687 @default.
• W2571279353 hasAuthorship W2571279353A5014867897 @default.
• W2571279353 hasAuthorship W2571279353A5020684790 @default.
• W2571279353 hasAuthorship W2571279353A5024492683 @default.
• W2571279353 hasAuthorship W2571279353A5025887498 @default.
• W2571279353 hasAuthorship W2571279353A5026632776 @default.
• W2571279353 hasAuthorship W2571279353A5030685440 @default.
• W2571279353 hasAuthorship W2571279353A5033267787 @default.
• W2571279353 hasAuthorship W2571279353A5034017455 @default.
• W2571279353 hasAuthorship W2571279353A5038541414 @default.
• W2571279353 hasAuthorship W2571279353A5039118991 @default.
• W2571279353 hasAuthorship W2571279353A5039374832 @default.
• W2571279353 hasAuthorship W2571279353A5040369089 @default.
• W2571279353 hasAuthorship W2571279353A5045067253 @default.
• W2571279353 hasAuthorship W2571279353A5046784402 @default.

• next